Axiostat Gauze— 510(k) K222909

Substantially Equivalent

Advamedica, Inc.

FDA 510(k) clearance K222909 for Axiostat Gauze, Substantially Equivalent on 2023-04-07. Applicant: Advamedica, Inc..

Clearance details

Applicant: Advamedica, Inc.
Product code: Code QSY
Advisory panel: Unknown
Date received: 2022-09-26
Decision date: 2023-04-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cambridge, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code QSY

product code QSY

Death: 5
Other: 1
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.